Organic compounds -- part of the class 532-570 series – Organic compounds – Sulfinate esters
Reexamination Certificate
2008-07-29
2008-07-29
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Sulfinate esters
C562S008000, C558S154000, C558S193000, C558S190000
Reexamination Certificate
active
11232252
ABSTRACT:
Novel phosphate-bearing prodrugs of sulfonyl hydrazines have the formula presented below. Pharmaceutical compositions and uses thereof in the treatment of cancer are claimed. The aforementioned prodrugs include enantiomers, stereoisomers and tautomers thereof, as well as pharmaceutically acceptable salts or solvates and metabolites from all stages. The aforementioned prodrugs are preferentially activated in hypoxic tumors and can be given either alone, or in combination with other anticancer agents or with phototheraphy or radiotherapy.where R is C1-C10alkyl or haloalkyl;R′ and R″ are each independently C1-C10alkyl;R1is CH3; andX is O;or a pharmaceutically acceptable salt, solvate, polymorph or metabolite thereof.
REFERENCES:
patent: 4684747 (1987-08-01), Sartorelli et al.
patent: 4849563 (1989-07-01), Sartorelli et al.
patent: 5101072 (1992-03-01), Sartorelli et al.
patent: 5214068 (1993-05-01), Sartorelli et al.
patent: 5256820 (1993-10-01), Sartorelli et al.
patent: 5637619 (1997-06-01), Sartorelli et al.
patent: 5767134 (1998-06-01), Li et al.
patent: 6040338 (2000-03-01), Sartorelli et al.
patent: 6458816 (2002-10-01), Doyle et al.
patent: 6855695 (2005-02-01), Lin et al.
Hockel et al., Cancer Res. 1991, 51:6098.
Brizel et al., Radiother Oncol. 1999, 53:113.
Stratford et al, Anticancer Drug Des. 1998, 13:519.
Ashur-Fabian et al., Proc. Natl. Acad. Sci. USA 2004. 101:12236.
Yang et al., Cancer Res. 2003, 63:1520.
Korbelik et al., Mutal. Res. 1980, 78:201.
Shealy et al., J. Med. Chem. 1984, 27:664.
Shyam et al., J.Med. Chem. 1999, 42:941.
Seow et al., Proc. Natl. Acad. Sci. USA 2005, 102:9282.
Shyam et al., J. Med. Chem. 1993, 36:3496.
Shyam et al., J. Med. Chem. 1996, 39:796.
Majer et al., J. Org. Chem. 1994, 59:1937.
Pridgen et al., J. Org. Chem. 1989, 54:3231.
Matulic-Adamic et al., J. Org. Chem. 1995, 60:2563.
Durgam et al., J. Med. Chem. 2005, 48:4919.
Jansson et al., Tetrahedron Lett. 1986, 27:753.
Mathre et al., J. Org. Chem. 1993, 58:2880.
Brown et al., J. Am. Chem. Soc. 1988, 110:1539.
Ramachadran et al., Tetrahedron: Asymm. 5: 1061.
Ohkuma et al., J. Am. Chem. Soc. 1998, 120:13529.
Baar et al., J. Am. Chem. Soc. 2004, 126:8216.
Silverberg et al., Tetrahedron Lett. 1996, 37:771.
Belcourt Michael F.
Doyle Terrence W.
King Ivan
Lin Xu
Anderson Rebecca
Chu Yong
Coleman Henry D.
Sapone William J.
Sudol R. Neil
LandOfFree
Phosphate-bearing prodrugs of sulfonyl hydrazines as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphate-bearing prodrugs of sulfonyl hydrazines as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphate-bearing prodrugs of sulfonyl hydrazines as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3934484